Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
9.75
+0.11 (1.14%)
At close: Aug 26, 2026, 4:00 PM EDT
9.75
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:41 PM EDT

Orthofix Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-61.72-92.19-126-151.4-19.75-38.38
Depreciation & Amortization
58.4962.3275.9660.5632.0833.1
Loss (Gain) From Sale of Assets
0.961.142.032.32.07-
Asset Writedown & Restructuring Costs
-20.93---11.76
Loss (Gain) From Sale of Investments
-0.03-0.057.530.6-0.31-1.15
Stock-Based Compensation
28.6628.6932.4635.7118.4415.43
Provision & Write-off of Bad Debts
4.012.2620.822.10.44
Other Operating Activities
19.8531.7551.0759.62-2.0232.8
Change in Accounts Receivable
-10.75-1.58-9.53-10.41-6.74-7.05
Change in Inventory
-25.78-10.75-5.55-58.05-33.04-10.21
Change in Accounts Payable
12.222.6-5.578.642.284.25
Change in Unearned Revenue
-----4.79-9.06
Change in Other Net Operating Assets
-9.64-11.771.395.86-1.86-13.46
Operating Cash Flow
16.2733.3525.79-45.75-11.5418.48
Operating Cash Flow Growth
-43.23%29.30%----75.13%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-44.09-34.63-34.88-62.05-23.16-17.79
Cash Acquisitions
---29.42--
Sale (Purchase) of Intangibles
------1.81
Investment in Securities
--7.4-0.13-2.17
Other Investing Activities
0.160.03-0.1-0.5-1.5-1.25
Investing Cash Flow
-43.93-34.6-27.58-33.13-24.53-23.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--197.6174.5--
Total Debt Issued
64.03-197.6174.5--
Long-Term Debt Repaid
--0.76-143.21-106.55-2.59-0.54
Total Debt Repaid
-0.44-0.76-143.21-106.55-2.59-0.54
Net Debt Issued (Repaid)
63.58-0.7654.3967.95-2.59-0.54
Issuance of Common Stock
5.55.936.265.134.348.82
Repurchase of Common Stock
-0.42-0.43-5.31-4.4-1.73-2.56
Other Financing Activities
-5.01-5.52-4.63-3.36-0.09-9.35
Financing Cash Flow
63.65-0.7950.7165.32-0.08-3.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.271.41-0.940.62-1-0.82
Net Cash Flow
35.72-0.6247.98-12.94-37.15-8.97

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-27.82-1.28-9.09-107.8-34.70.69
Free Cash Flow Growth
------98.66%
Free Cash Flow Margin
-3.34%-0.16%-1.14%-14.44%-7.53%0.15%
Free Cash Flow Per Share
-0.69-0.03-0.24-2.94-1.730.04
Levered Free Cash Flow
4.127.3255.42-140.87-36.1820.23
Unlevered Free Cash Flow
17.0938.2573.94-135.48-35.3721.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
17.317.316.95.81.41.5
Cash Income Tax Paid
1.61.61.30.9-0.94.8
Change in Working Capital
-33.95-21.5-19.25-53.96-44.14-35.52
SEC Filings: 10-K · 10-Q